Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 31-45 of 101
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiersExploring Metabolomics in Multiple Sclerosis
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiersMetabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Managing Multiple Sclerosis: The Impact of Dietary Modifications
On the Frontlines of Multiple SclerosisManaging Multiple Sclerosis: The Impact of Dietary Modifications
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple SclerosisStrategies and Considerations for Managing MS in Pregnant Women
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiersCognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiersMultiple Sclerosis Explained: Understanding Its Epidemiology
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiersGeneralized Myasthenia Gravis Management: Evaluating Long-Term Effects
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiersSocial Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
Navigating Neuromuscular Diseases: CHEST Guidelines for Respiratory Care
NeuroFrontiersNavigating Neuromuscular Diseases: CHEST Guidelines for Respiratory Care
Respiratory Challenges in Neuromuscular Disorders: A Look at Symptoms and Impacts
NeuroFrontiersRespiratory Challenges in Neuromuscular Disorders: A Look at Symptoms and Impacts
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiersGaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiersUnderstanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
On the Frontlines of Multiple SclerosisManaging MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
